Literature DB >> 22913740

The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2.

Elodie Jouan1, Marc Le Vee, Claire Denizot, Georges Da Violante, Olivier Fardel.   

Abstract

Rhodamine 123 is a fluorescent cationic dye commonly used as a mitochondrial probe and known or suspected to be transported by certain drug membrane transporters. The present study was designed to characterize the putative interactions of rhodamine 123 with human organic cation transporter (OCT) 1 and OCT2. Intracellular uptake of the dye was demonstrated to be enhanced in both hOCT1- and hOCT2-overexpressing HEK293 cells when compared with control HEK293 cells. This increase of rhodamine 123 influxes was found to be a saturable carrier-mediated process, with low K(m) values (K(m) = 0.54 μm and K(m) = 0.61 μm for transport of the dye in hOCT1- and hOCT2-positive HEK293 cells, respectively). Known inhibitors of hOCT1 and hOCT2 activities such as verapamil, amitriptyline, prazosin, and quinine were next demonstrated to decrease rhodamine 123 accumulation in hOCT1- and hOCT2-overexpressing HEK293 cells. In addition, the dye was found to inhibit hOCT1- and hOCT2-mediated uptake of tetraethylammonium (TEA), a model substrate for both hOCT1 and hOCT2; rhodamine 123 appeared nevertheless to be a more potent inhibitor of hOCT1-mediated TEA transport (IC₅₀ = 0.37 μm) than of that mediated by hOCT2 (IC₅₀ = 61.5 μm). Taken together, these data demonstrate that rhodamine 123 is a high-affinity substrate for both hOCT1 and hOCT2. This dye may be therefore useful for fluorimetrically investigating cellular hOCT1 or hOCT2 activity, knowing, however, that other factors potentially contributing to cellular accumulation of rhodamine 123, including mitochondrial membrane potential or expression of the efflux transporter P-glycoprotein, have also to be considered.
© 2012 The Authors Fundamental and Clinical Pharmacology © 2012 Société Française de Pharmacologie et de Thérapeutique.

Entities:  

Keywords:  drug transport; organic cation transporter 1; organic cation transporter 2; rhodamine 123

Mesh:

Substances:

Year:  2012        PMID: 22913740     DOI: 10.1111/j.1472-8206.2012.01071.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  16 in total

1.  Culture and analysis of kidney tubuloids and perfused tubuloid cells-on-a-chip.

Authors:  Linda Gijzen; Fjodor A Yousef Yengej; Frans Schutgens; Marianne K Vormann; Carola M E Ammerlaan; Arnaud Nicolas; Dorota Kurek; Paul Vulto; Maarten B Rookmaaker; Henriette L Lanz; Marianne C Verhaar; Hans Clevers
Journal:  Nat Protoc       Date:  2021-03-05       Impact factor: 13.491

2.  Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices.

Authors:  Ondrej Martinec; Martin Huliciak; Frantisek Staud; Filip Cecka; Ivan Vokral; Lukas Cerveny
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

3.  The effect of ciprofloxacin on doxorubicin cytotoxic activity in the acquired resistance to doxorubicin in DU145 prostate carcinoma cells.

Authors:  Asieh Davary Avareshk; Jamileh Gholami; Razieh Jalal
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

4.  Copper Oxide Nanoparticles Exhibit Cell Death Through Oxidative Stress Responses in Human Airway Epithelial Cells: a Mechanistic Study.

Authors:  Nida N Farshori; Maqsood A Siddiqui; Mai M Al-Oqail; Ebtesam S Al-Sheddi; Shaza M Al-Massarani; Maqusood Ahamed; Javed Ahmad; Abdulaziz A Al-Khedhairy
Journal:  Biol Trace Elem Res       Date:  2022-01-08       Impact factor: 4.081

Review 5.  Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models.

Authors:  Bastian Haberkorn; Martin F Fromm; Jörg König
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

6.  Tubuloids derived from human adult kidney and urine for personalized disease modeling.

Authors:  Frans Schutgens; Maarten B Rookmaaker; Thanasis Margaritis; Anne Rios; Carola Ammerlaan; Jitske Jansen; Linda Gijzen; Marianne Vormann; Annelotte Vonk; Marco Viveen; Fjodor Yousef Yengej; Sepide Derakhshan; Karin M de Winter-de Groot; Benedetta Artegiani; Ruben van Boxtel; Edwin Cuppen; Antoni P A Hendrickx; Marry M van den Heuvel-Eibrink; Ellen Heitzer; Henriette Lanz; Jeffrey Beekman; Jean-Luc Murk; Rosalinde Masereeuw; Frank Holstege; Jarno Drost; Marianne C Verhaar; Hans Clevers
Journal:  Nat Biotechnol       Date:  2019-03-04       Impact factor: 68.164

7.  Protein Kinase C-Independent Inhibition of Organic Cation Transporter 1 Activity by the Bisindolylmaleimide Ro 31-8220.

Authors:  Abdullah Mayati; Arnaud Bruyere; Amélie Moreau; Elodie Jouan; Claire Denizot; Yannick Parmentier; Olivier Fardel
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

8.  P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model.

Authors:  Chris E Adkins; Rajendar K Mittapalli; Vamshi K Manda; Mohamed I Nounou; Afroz S Mohammad; Tori B Terrell; Kaci A Bohn; Celik Yasemin; Tiffany R Grothe; Julie A Lockman; Paul R Lockman
Journal:  Front Pharmacol       Date:  2013-11-04       Impact factor: 5.810

9.  Rifampicin Induces Gene, Protein, and Activity of P-Glycoprotein (ABCB1) in Human Precision-Cut Intestinal Slices.

Authors:  Ondrej Martinec; Carin Biel; Inge A M de Graaf; Martin Huliciak; Koert P de Jong; Frantisek Staud; Filip Cecka; Peter Olinga; Ivan Vokral; Lukas Cerveny
Journal:  Front Pharmacol       Date:  2021-06-09       Impact factor: 5.810

10.  Evaluation of P-Glycoprotein Inhibitory Potential Using a Rhodamine 123 Accumulation Assay.

Authors:  Elodie Jouan; Marc Le Vée; Abdullah Mayati; Claire Denizot; Yannick Parmentier; Olivier Fardel
Journal:  Pharmaceutics       Date:  2016-04-12       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.